Criteria for use of composite end points for competing risks—a systematic survey of the literature with recommendations-Reference-Cited by-同舟云学术

Criteria for use of composite end points for competing risks—a systematic survey of the literature with recommendations

Published:2017-02 Issue: Volume:82 Page:4-11
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Manja Veena^ORCID,AlBashir Siwar^ORCID,Guyatt Gordon

Publisher

Elsevier BV

Subject

Epidemiology

Reference32 articles.

1. Composite outcomes in randomized trials: greater precision but with greater uncertainty?;Freemantle;JAMA,2003

2. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials;Ferreira-Gonzalez;BMJ,2007

3. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review;Cordoba;BMJ,2010

4. Endpoints used for relative effectiveness assessment of pharmaceuticals - composite endpoints. Methodological guidelines for rapid relative effectiveness assessment (REA) of Pharmaceuticals developed in WP5 of EUnetHTA JA,2013

5. Composite outcomes in cardiovascular research: a survey of randomized trials;Lim;Ann Intern Med,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing Risks in Clinical Trials;Journal of the American College of Cardiology;2024-09

2. Appropriateness and Quality of Composite Endpoint Use and Reporting in Spine Surgery;JBJS Reviews;2024-07

3. Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes;Diabetes & Metabolism;2024-07

4. Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study;Diabetes & Metabolism;2024-07

5. Real-World Assessment of Recommended COVID-19 Vaccination Waiting Period after Chemotherapy;Vaccines;2024-06-18